Surreal illustration representing the interconnectedness of memory loss, aging, and behavioral changes in Alzheimer's disease.

Beyond Memory Loss: Understanding and Managing Behavioral Changes in Alzheimer's

Jordan Keane in Health & Wellness December 2025 • 3 min read.

"A practical guide to recognizing, addressing, and improving the quality of life for individuals experiencing behavioral and psychological symptoms of Alzheimer's disease."

Alzheimer's disease (AD) is often primarily associated with memory loss, but the condition also brings a range of behavioral and psychological symptoms (BPSD) that can significantly impact patients and caregivers. These symptoms, which include agitation, depression, delusions, and aggression, present complex challenges in care and management.

In Japan, there are restrictions on medicines specifically approved for treating BPSD in AD, and atypical antipsychotics are used cautiously due to concerns about increased mortality in elderly patients. Despite these limitations, managing BPSD is crucial for improving the quality of life for those living with AD.

This article explores the intricate relationship between aging, disease progression, and BPSD in Alzheimer's disease. We aim to provide practical insights into understanding and managing these challenging symptoms, drawing from research and clinical implications to inform effective care strategies.

Unraveling the Link: How Aging and Alzheimer's Shape Behavior

Surreal illustration representing the interconnectedness of memory loss, aging, and behavioral changes in Alzheimer's disease.

To better understand how aging and disease progression affect BPSD in AD, a study evaluated patients referred for AD treatment due to their BPSD. Researchers collected demographic data, assessed cognitive function using the Mini-Mental State Examination (MMSE), and evaluated BPSD using the Behavioral Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD).

The study divided Alzheimer's patients into groups based on age and cognitive performance to analyze how these factors influence the manifestation of BPSD. This approach revealed key insights into how these symptoms evolve as the disease progresses.

Age-Related Differences: Older patients exhibited a connection between psychotic symptoms (delusions, hallucinations) and mood disturbances (anxiety, phobia), suggesting that these symptoms can merge as individuals age.
Cognitive Performance: Patients with lower MMSE scores showed a merging of psychotic symptoms, mood disturbances, and aggressiveness, indicating that cognitive decline can lead to a convergence of behavioral issues.

These findings suggest that as Alzheimer’s disease advances, the distinct categories of BPSD may become less defined, requiring a more integrated approach to treatment and care.

Optimizing Treatment Strategies: A Path Forward

Considering the complex interplay between aging, cognitive decline, and BPSD, treatment strategies should be carefully tailored to each patient's unique presentation. A key consideration is whether to treat the underlying depression or target the psychotic symptoms directly. The research suggests that in later stages of AD, it may be more effective to address the mood and behavioral symptoms together, given their interconnectedness.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What are the common behavioral and psychological symptoms (BPSD) associated with Alzheimer's disease?

The behavioral and psychological symptoms (BPSD) of Alzheimer's disease (AD) encompass a range of challenges. These include agitation, depression, delusions, and aggression. These symptoms can significantly impact both the individuals diagnosed with AD and their caregivers, making management crucial for improving the quality of life for those living with AD.

How does aging influence the manifestation of behavioral and psychological symptoms (BPSD) in Alzheimer's disease?

A study evaluated patients referred for AD treatment. The results suggested that older patients exhibited a connection between psychotic symptoms (delusions, hallucinations) and mood disturbances (anxiety, phobia). This indicates that as individuals age, these distinct categories of BPSD can merge. The interconnectedness necessitates an integrated approach to treatment, addressing both mood and psychotic symptoms concurrently.

What role does cognitive decline play in the convergence of behavioral and psychological symptoms (BPSD) in Alzheimer's disease?

Cognitive decline, as assessed by the Mini-Mental State Examination (MMSE), is a significant factor in the manifestation of BPSD. Patients with lower MMSE scores showed a merging of psychotic symptoms, mood disturbances, and aggressiveness. This convergence highlights that as Alzheimer’s disease progresses and cognitive abilities diminish, the distinct categories of BPSD become less defined, demanding a more holistic and integrated care strategy.

Are there any limitations in the treatment of behavioral and psychological symptoms (BPSD) in Alzheimer's disease?

Yes, there are limitations, particularly regarding pharmacotherapy. In Japan, there are restrictions on medicines specifically approved for treating BPSD in AD. Moreover, atypical antipsychotics are used cautiously due to concerns about increased mortality in elderly patients. Despite these challenges, managing BPSD is paramount for improving the quality of life for those living with AD, and the implications underscore the need for alternative or complementary therapeutic approaches.

How should treatment strategies for behavioral and psychological symptoms (BPSD) be optimized in Alzheimer's disease?

Treatment strategies should be carefully tailored to each patient's unique presentation, considering the complex interplay between aging, cognitive decline, and BPSD. A critical consideration is whether to treat the underlying depression or target the psychotic symptoms directly. The research suggests that in later stages of AD, it may be more effective to address the mood and behavioral symptoms together, given their interconnectedness. This integrated approach can lead to better outcomes and improved quality of life for patients.